FRANKLIN LAKES, N.J., October 27, 2025 / Biotech Newswire / --

弗兰克林湖，新泽西州，2025年10月27日 /生物技术新闻社/ --

BD

蓝光光盘

(Becton, Dickinson and Company), a leading medical technology company, will feature the next generation of drug delivery and traceability solutions at

(Becton, Dickinson and Company)，一家领先的医疗技术公司，将展示下一代药物输送和可追溯性解决方案。

CPhI 2025 on

2025年CPhI展会

October 28-30 in Frankfurt, Germany.

10月28日至30日，德国法兰克福。

The event is a premier global platform for pharmaceutical professionals, focusing on innovations in drug delivery and packaging systems.

该活动是面向制药行业专业人士的全球顶级平台，重点关注药物输送和包装系统的创新。

BD will showcase several technologies that help pharmaceutical and biotechnology companies advance the delivery of complex therapies — from high-viscosity biologics and GLP-1s to connected traceability systems that transform fill-finish operations.

BD将展示多项技术，这些技术帮助制药和生物技术公司推进复杂疗法的交付——从高粘度生物制品和GLP-1到转变填充完成操作的连接追溯系统。

Enabling next-generation biologic delivery

启用下一代生物制品递送

At CPhl, BD will highlight innovations that address growing demand for devices capable of delivering higher-volume, higher-viscosity drugs and enabling patient self-administration outside of traditional care settings.

在CPhl上，BD将重点展示创新成果，以满足市场对能够递送更高容量、更高粘度药物并使患者能够在传统护理环境之外进行自我给药的设备日益增长的需求。

Visitors can explore live demonstrations of:

参观者可以探索以下现场演示：

Driving new standards in fill-finish traceability

推动灌装完成追溯性的新标准

For the first time at CPhI, BD will host the

在CPhI上，BD将首次主办

BD iDiFill™ RFID Integration Tour

BD iDiFill™ RFID集成巡回展

, offering attendees an exclusive live demonstration of unit-level RFID traceability across the fill-finish process.

，为与会者提供在灌装完成过程中单位级别 RFID 可追溯性的独家现场演示。

The guided tour will connect multiple manufacturing partners —

此次导览将连接多个制造合作伙伴——

BD, Bausch + Ströbel, Körber, and Harro Höfliger

BD、博世+斯托贝尔、科伯、哈罗霍弗林

and feature insights from

并提供功能洞察

ten23 health

十23健康

— to showcase how

——以展示如何

BD iDiFill™ Individual Prefillable Syringe Identification

BD iDiFill™ 单剂量预灌封注射器识别

supports regulatory compliance, manufacturing excellence, and data integrity from filling to final assembly.

支持从灌装到最终组装的法规合规、制造卓越和数据完整性。

Attendees can reserve a spot for this guided experience and see how RFID-enabled prefillable syringes are shaping the future of pharmaceutical manufacturing.

与会者可以为这次有指导的体验预留一个位置，了解支持 RFID 的预填充注射器如何塑造制药生产的未来。

BD iDFill Tour RFID Integration Tour - CPHI 2025

BD iDFill Tour RFID集成巡回展 - CPHI 2025

Integrated services to accelerate combination product development

加速组合产品开发的综合服务

BD and ZebraSci™ will also present a comprehensive range of combination product development services that support customers from concept through launch.

BD 和 ZebraSci™ 还将提供一系列全面的组合产品开发服务，支持客户从概念到上市的全过程。

A continued commitment to partnership and innovation

对合作伙伴关系和创新的持续承诺

“At BD, our mission is to make advanced drug delivery both possible and practical — enabling patients to receive complex biologics safely and conveniently, whenever and wherever,”

“在BD，我们的使命是让先进的药物输送既可能又实用——使患者能够安全、便捷地接受复杂的生物制剂，无论何时何地。”

said Fernand Goldblat, VP/GM, BD Medical – Pharmaceutical Systems, PFS Platform.

BD医疗制药系统PFS平台副总裁兼总经理费尔南·戈尔德布拉特说道。

“Our participation at CPhI underscores BD’s long-term commitment to collaborating with pharmaceutical and biotechnology partners to develop the next-generation of combination products and manufacturing solutions.”

“我们参加CPhI展会，彰显了BD与制药和生物技术合作伙伴长期合作的承诺，共同开发下一代组合产品和制造解决方案。”

BD will also display a selection of its broader drug delivery portfolio, including:

BD还将展示其更广泛的药物输送产品组合，包括：

Visit BD at CPhI 2025

访问BD在CPhI 2025

Attendees can visit

与会者可以访问

BD at booth #8.0C60

BD在展位#8.0C60。

to meet BD experts, participate in live product demonstrations, and explore how BD’s integrated portfolio is shaping the future of drug delivery and traceability.

与BD专家会面，参与产品现场演示，并探索BD的综合产品组合如何塑造药物输送和可追溯性的未来。

For more information, visit [bd.com/CPhI2025] or follow BD on LinkedIn and X for event updates.

有关更多信息，请访问 [bd.com/CPhI2025] 或在 LinkedIn 和 X 上关注 BD 以获取活动更新。

About

关于

BD

蓝光光盘

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.

BD是全球最大的医疗技术公司之一，通过改进医疗发现、诊断和护理服务来推动健康领域的进步。该公司通过开发创新的技术、服务和解决方案，支持医疗保健领域的前线英雄，帮助推进患者的临床治疗和医疗保健提供者的临床流程。

BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues.

BD及其77,000名员工充满热情并致力于帮助提升临床医生护理过程的安全性和效率，使实验室科学家能够准确检测疾病，并推动研究人员开发下一代诊断和治疗方法的能力。BD几乎在每个国家都有业务，并与全球各地的组织合作，共同应对一些最具挑战性的全球健康问题。

By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit .

通过与客户密切合作，BD可以帮助改善结果、降低成本、提高效率、增强安全性并扩大医疗保健的可及性。有关BD的更多信息，请访问。

bd.com

百度.com

or connect with us on LinkedIn at

或通过以下方式在LinkedIn上与我们联系

www.linkedin.com/company/bd1/

www.linkedin.com/company/bd1/

and Twitter

和Twitter

@BDandCo

@BDandCo

.

。

Contacts

联系人

Media

媒体

Fallon Mcloughlin

福隆·麦克劳克林

Director, Public Relations

公共关系总监

+1 201.258.0361

+1 201.258.0361

This email address is being protected from spambots. You need JavaScript enabled to view it.

该电子邮件地址正受到防垃圾邮件程序的保护。您需要启用 JavaScript 才能查看它。

Investors

投资者

Adam Reiffe

亚当·雷费

VP, Investor Relations

副总裁，投资者关系

+1 201.847.6927

+1 201.847.6927

This email address is being protected from spambots. You need JavaScript enabled to view it.

该电子邮件地址正受到防垃圾邮件机器人的保护。您需要启用 JavaScript 才能查看它。

1. BD SCF™ PremiumCoat® Plunger Stopper 1-3mL Customer quality specifications. Le Pont-de-Claix, France; Becton, Dickinson and Company; 2023.

1. BD SCF™ PremiumCoat® 活塞塞 1-3毫升 客户质量规格。法国勒蓬德克莱；贝克顿、迪金森公司；2023年。

* When compared to the BD SCF™ FluroTec® Plunger Stopper. Results are based on a sample of 100 pieces of BD Flurotec® and BD SCF™ PremiumCoat®. Variables compared were Mean (glide force reduction) and standard deviation (glide force variability).

* 与BD SCF™ FluroTec® Plunger Stopper相比。结果基于100件BD Flurotec®和BD SCF™ PremiumCoat®的样本。比较的变量为平均值（滑动力减少）和标准差（滑动力变化）。

BD Libertas™ Wearable Injector is a product in development; some statements are forwarding looking and are subject to a variety of risks and uncertainties.

BD Libertas™ 可穿戴注射器是一款正在开发中的产品；部分声明具有前瞻性，存在多种风险和不确定性。

BD iDiFill™ Individual Prefillable Syringe Identification is under development and is not a released product; statements contained herein are forward-looking and are subject to a variety of risks and uncertainties. Actual product may vary.

BD iDiFill™ 个体预灌装注射器识别系统正在开发中，尚未发布；本文中的声明是前瞻性的，可能面临多种风险和不确定性。实际产品可能会有所不同。

PremiumCoat is a registered trademark of AptarGroup, Inc.

PremiumCoat 是 AptarGroup, Inc. 的注册商标。

FluroTec is a registered trademark of West Pharmaceutical Services, Inc.

FluroTec 是 West Pharmaceutical Services, Inc. 的注册商标。

Keywords: Marketing; Drug Delivery Systems; Syringes; Glass;  Injections; Technology; Hospitals; Self Administration; Wearable Electronic Devices; Radio Frequency Identification Device; Viscosity; Glucagon-Like Peptide 1; Equipment Design; Biological Products; BD; Becton, Dickinson and Company; CPhI 2025; Frankfurt, Germany; drug delivery; traceability solutions; pharmaceutical packaging; biotechnology; high-viscosity biologics; GLP-1 therapies; traceability systems; fill-finish operations; home-based care; BD Libertas™ Wearable Injector; subcutaneous delivery; large-volume drug delivery; single-use injector; BD Neopak™ XtraFlow™ Glass Prefillable Syringe; BD SCF™ PremiumCoat® Plunger Stopper; high-viscosity biologic delivery; fill-finish traceability; BD iDiFill™ RFID Integration Tour; RFID-enabled prefillable syringes; regulatory compliance; pharmaceutical manufacturing; BD Effivax™ Glass Prefillable Syringe; BD Hylok™ Prefillable Syringe; BD Physioject™ Disposable Autoinjector; BD Vystra™ Disposable Pen.

关键词：营销；药物输送系统；注射器；玻璃；注射；技术；医院；自我给药；可穿戴电子设备；射频识别设备；粘度；胰高血糖素样肽1；设备设计；生物制品；BD；贝克顿·迪金森公司；2025年CPhI展会；德国法兰克福；药物递送；可追溯性解决方案；医药包装；生物技术；高粘度生物制品；GLP-1疗法；可追溯系统；灌装完成操作；家庭护理；BD Libertas™ 可穿戴注射器；皮下递送；大容量药物递送；一次性注射器；BD Neopak™ XtraFlow™ 玻璃预填充注射器；BD SCF™ PremiumCoat® 活塞塞；高粘度生物制品递送；灌装完成可追溯性；BD iDiFill™ RFID集成巡展；支持RFID的预填充注射器；法规合规；制药生产；BD Effivax™ 玻璃预填充注射器；BD Hylok™ 预填充注射器；BD Physioject™ 一次性自动注射器；BD Vystra™ 一次性笔式注射器。

Source: Biotech Newswire

来源：生物技术新闻专线